Patents by Inventor Christine Klinguer-Hamour

Christine Klinguer-Hamour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid

Publication number: 20030175285

Abstract: The invention concerns a molecule of pharmaceutical interest, preferably a major histocompatibility complex (MHC) ligand, comprising a glutamic acid or a glutamine at its N-terminal, in the form of a physiologically acceptable addition salt, and a vaccine comprising such a ligand.

Type: Application

Filed: September 19, 2002

Publication date: September 18, 2003

Inventors: Christine Klinguer-Hamour, Corvaia Nathalie, Beck Alain, Goetsch Liliane

prev 1 2

Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid